CA2901429C - Codes a barres recouverts par des nanocoques metalliques - Google Patents
Codes a barres recouverts par des nanocoques metalliques Download PDFInfo
- Publication number
- CA2901429C CA2901429C CA2901429A CA2901429A CA2901429C CA 2901429 C CA2901429 C CA 2901429C CA 2901429 A CA2901429 A CA 2901429A CA 2901429 A CA2901429 A CA 2901429A CA 2901429 C CA2901429 C CA 2901429C
- Authority
- CA
- Canada
- Prior art keywords
- barcode
- nanoshell
- metal
- target
- barcodes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002078 nanoshell Substances 0.000 title claims abstract description 191
- 239000002184 metal Substances 0.000 title claims abstract description 147
- 229910052751 metal Inorganic materials 0.000 title claims abstract description 147
- 238000000034 method Methods 0.000 claims abstract description 75
- 238000001514 detection method Methods 0.000 claims abstract description 64
- 239000000523 sample Substances 0.000 claims description 146
- 239000002096 quantum dot Substances 0.000 claims description 97
- 239000011325 microbead Substances 0.000 claims description 92
- 229920000642 polymer Polymers 0.000 claims description 80
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 68
- 229910052709 silver Inorganic materials 0.000 claims description 68
- 239000004332 silver Substances 0.000 claims description 68
- 239000004793 Polystyrene Substances 0.000 claims description 33
- 229920002223 polystyrene Polymers 0.000 claims description 33
- 229920000147 Styrene maleic anhydride Polymers 0.000 claims description 21
- 108090000623 proteins and genes Proteins 0.000 claims description 19
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 18
- 239000010931 gold Substances 0.000 claims description 18
- 229910052737 gold Inorganic materials 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 15
- 102000004169 proteins and genes Human genes 0.000 claims description 14
- 239000002082 metal nanoparticle Substances 0.000 claims description 12
- 238000010899 nucleation Methods 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 239000011147 inorganic material Substances 0.000 claims description 8
- 150000007523 nucleic acids Chemical class 0.000 claims description 8
- 239000011368 organic material Substances 0.000 claims description 8
- 229910010272 inorganic material Inorganic materials 0.000 claims description 6
- 150000002632 lipids Chemical class 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 108020004707 nucleic acids Proteins 0.000 claims description 5
- 102000039446 nucleic acids Human genes 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 5
- 230000001268 conjugating effect Effects 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 229920001542 oligosaccharide Polymers 0.000 claims description 4
- 150000002482 oligosaccharides Chemical class 0.000 claims description 4
- 230000027455 binding Effects 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims description 3
- 150000001732 carboxylic acid derivatives Chemical group 0.000 claims description 2
- 239000011324 bead Substances 0.000 description 70
- 238000003556 assay Methods 0.000 description 35
- 230000035945 sensitivity Effects 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 108020004414 DNA Proteins 0.000 description 14
- 239000000872 buffer Substances 0.000 description 14
- 239000011257 shell material Substances 0.000 description 13
- 241000223960 Plasmodium falciparum Species 0.000 description 12
- 230000008569 process Effects 0.000 description 10
- 241000223810 Plasmodium vivax Species 0.000 description 9
- 238000004891 communication Methods 0.000 description 9
- 230000021615 conjugation Effects 0.000 description 9
- 241000894007 species Species 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000000684 flow cytometry Methods 0.000 description 8
- 201000004792 malaria Diseases 0.000 description 8
- ZMBHCYHQLYEYDV-UHFFFAOYSA-N trioctylphosphine oxide Chemical compound CCCCCCCCP(=O)(CCCCCCCC)CCCCCCCC ZMBHCYHQLYEYDV-UHFFFAOYSA-N 0.000 description 8
- 238000005119 centrifugation Methods 0.000 description 7
- 230000007613 environmental effect Effects 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical class [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 description 6
- 239000003446 ligand Substances 0.000 description 6
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000002498 deadly effect Effects 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 239000007987 MES buffer Substances 0.000 description 4
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000012472 biological sample Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical group CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 4
- 229940099500 cystamine Drugs 0.000 description 4
- 238000000295 emission spectrum Methods 0.000 description 4
- 238000004626 scanning electron microscopy Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 231100000673 dose–response relationship Toxicity 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002073 fluorescence micrograph Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 229910001961 silver nitrate Inorganic materials 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 125000003396 thiol group Chemical group [H]S* 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 208000002476 Falciparum Malaria Diseases 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 208000009182 Parasitemia Diseases 0.000 description 2
- 208000030852 Parasitic disease Diseases 0.000 description 2
- 201000011336 Plasmodium falciparum malaria Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000011258 core-shell material Substances 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 230000009260 cross reactivity Effects 0.000 description 2
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 238000007306 functionalization reaction Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000006862 quantum yield reaction Methods 0.000 description 2
- 229920005604 random copolymer Polymers 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000001878 scanning electron micrograph Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000006557 surface reaction Methods 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- YBNMDCCMCLUHBL-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 4-pyren-1-ylbutanoate Chemical class C=1C=C(C2=C34)C=CC3=CC=CC4=CC=C2C=1CCCC(=O)ON1C(=O)CCC1=O YBNMDCCMCLUHBL-UHFFFAOYSA-N 0.000 description 1
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- 229910004613 CdTe Inorganic materials 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 1
- 206010035500 Plasmodium falciparum infection Diseases 0.000 description 1
- 241000223821 Plasmodium malariae Species 0.000 description 1
- 206010035501 Plasmodium malariae infection Diseases 0.000 description 1
- 241001505293 Plasmodium ovale Species 0.000 description 1
- 206010035502 Plasmodium ovale infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- XCAUINMIESBTBL-UHFFFAOYSA-N lead(ii) sulfide Chemical compound [Pb]=S XCAUINMIESBTBL-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000007837 multiplex assay Methods 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 231100001160 nonlethal Toxicity 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000003335 steric effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- -1 thiolate amine Chemical class 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La présente invention concerne des codes à barres recouverts par des nanocoques métalliques et leurs procédés de fabrication. Les codes à barres recouverts par des nanocoques métalliques de la présente invention trouvent leurs applications dans des systèmes de détection, tels que des systèmes de détection multiplex.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2901429A CA2901429C (fr) | 2013-02-15 | 2014-02-14 | Codes a barres recouverts par des nanocoques metalliques |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361765366P | 2013-02-15 | 2013-02-15 | |
| US61/765,366 | 2013-02-15 | ||
| PCT/CA2013/050953 WO2014089700A1 (fr) | 2012-12-11 | 2013-12-11 | Système de détection à base de dispositif de communication sans fil |
| CAPCT/CA2013/050953 | 2013-12-11 | ||
| CA2901429A CA2901429C (fr) | 2013-02-15 | 2014-02-14 | Codes a barres recouverts par des nanocoques metalliques |
| PCT/CA2014/050108 WO2014124543A1 (fr) | 2013-02-15 | 2014-02-14 | Codes à barres recouverts par des nanocoques métalliques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2901429A1 CA2901429A1 (fr) | 2014-08-21 |
| CA2901429C true CA2901429C (fr) | 2023-12-12 |
Family
ID=54010687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2901429A Active CA2901429C (fr) | 2013-02-15 | 2014-02-14 | Codes a barres recouverts par des nanocoques metalliques |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2901429C (fr) |
-
2014
- 2014-02-14 CA CA2901429A patent/CA2901429C/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2901429A1 (fr) | 2014-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11473152B2 (en) | Metal nanoshell-coated barcodes | |
| Luan et al. | Ultrabright fluorescent nanoscale labels for the femtomolar detection of analytes with standard bioassays | |
| Wang et al. | Bioconjugated silica nanoparticles: development and applications | |
| Martynenko et al. | Magneto-fluorescent microbeads for bacteria detection constructed from superparamagnetic Fe3O4 nanoparticles and AIS/ZnS quantum dots | |
| Karakoti et al. | Surface functionalization of quantum dots for biological applications | |
| JP7539711B2 (ja) | 万能増強剤としての超高輝度蛍光ナノコンストラクト | |
| Valizadeh et al. | Quantum dots: synthesis, bioapplications, and toxicity | |
| US7846412B2 (en) | Bioconjugated nanostructures, methods of fabrication thereof, and methods of use thereof | |
| US8822955B2 (en) | Polymer-conjugated quantum dots and methods of making the same | |
| WO2011045394A1 (fr) | Marqueurs biomoléculaires impliquant des nanoparticules fonctionnalisées avec dendrimères | |
| Chen et al. | Fabrication of metal nanoshell quantum-dot barcodes for biomolecular detection | |
| CN112391347B (zh) | 磁-光复合纳米结构、其制造方法以及检测、分离或成像分析物的方法 | |
| KR102484477B1 (ko) | 자성-광학 복합구조 나노입자 | |
| Dembele et al. | Zwitterionic silane copolymer for ultra-stable and bright biomolecular probes based on fluorescent quantum dot nanoclusters | |
| Kim et al. | Encapsulation-stabilized, europium containing nanoparticle as a probe for time-resolved luminescence detection of cardiac troponin I | |
| Liu et al. | Luminescent Rhodamine B doped core–shell silica nanoparticle labels for protein microarray detection | |
| CA2901429C (fr) | Codes a barres recouverts par des nanocoques metalliques | |
| Doty et al. | Nanoscale science: a big step towards the Holy Grail of single molecule biochemistry and molecular biology. | |
| Zhao et al. | Fluorescent nanoparticle for bacteria and DNA detection | |
| EP2894475B1 (fr) | Capteur de mesure d'analyte | |
| KR20150126861A (ko) | 금속 나노쉘-코팅된 바코드 | |
| Vlasceanu et al. | Quantum dots for bioimaging and therapeutic applications | |
| Mattoussi et al. | Colloidal semiconductor quantum dot conjugates in biosensing | |
| Kim et al. | Development of an immobilized-antigen immunofluorescence glass slide system that exploits fluorescent silica nanoparticles | |
| KR102660706B1 (ko) | 자성-광학 복합기능 나노입자 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20190212 |
|
| EEER | Examination request |
Effective date: 20190212 |
|
| EEER | Examination request |
Effective date: 20190212 |
|
| EEER | Examination request |
Effective date: 20190212 |
|
| EEER | Examination request |
Effective date: 20190212 |
|
| EEER | Examination request |
Effective date: 20190212 |
|
| EEER | Examination request |
Effective date: 20190212 |
|
| EEER | Examination request |
Effective date: 20190212 |
|
| EEER | Examination request |
Effective date: 20190212 |